Lindeman GJ, Fernando TM, Bowen R, Jerzak KJ, et al. VERONICA: Randomized Phase 2 Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors - Efficacy, Safety, Biomarker Results. Clin Cancer Res 2022 May 18. pii: 699022. doi: 10.1158/1078-0432.CCR-21-3811.
PMID: 35583555